Search For "myeloma"
Advancement in therapies showcases long-term survival in multiple myeloma
Updated : 4 weeks, 1 day ago IST
Hospitals are reporting significant success in treating multiple myeloma, with patients undergoing advanced therapies, including a second autologous stem cell transplant,s have exhibited improved long-term survival rates.
Read More
HemeNext 2025: India's Premier Hematology Conference Unveils the Future of
Updated : 3 months, 2 weeks ago IST
Gurgaon (Haryana) [India], November 25: HemeNext 2025, held at The Westin Hotel, Gurgaon on the 22nd and 23rd of November, welcomed nearly 300 delegates from across the country, making it one of India's most anticipated gatherings in the field of hematology. Conceptualised and led by Dr Rahu
Read More
Clinicians at Fortis' S.L. Raheja Hospital Successfully Perform 1st Bone M
Updated : 4 months, 3 weeks ago IST
Mumbai (Maharashtra) [India], October 20: S.L. Raheja Hospital, Mahim - A Fortis Associate, has achieved a milestone in its clinical journey with the successful completion of its first-ever Bone Marrow Transplant (BMT) at the COE for Haemato-Oncology. The landmark procedure was performed on
Read More
"Country will miss her": Maithili Thakur remembers late singer Sharda Sinh
Updated : 5 months ago IST
Sharda Sinha, affectionately known as the "Bihar Kokila," was a beloved figure in the Indian music world, celebrated for her deep-rooted contribution to Bhojpuri and Maithili folk music. Sinha, 72, passed away on November 5, 2024, after a prolonged battle with multiple myeloma, a form of blo
Read More
Fortis Vashi Launches Specialised Blood Disorder Clinic
Updated : 9 months, 1 week ago IST
Navi Mumbai (Maharashtra) [India], June 6: Fortis Hiranandani Hospital, Vashi, today launched the Blood Disorder Clinic in Navi Mumbai--a pioneering center dedicated to the diagnosis, treatment, and management of blood-related conditions. The unit, helmed by Dr Subhaprakash Sanyal, Director-
Read More
BD India Provides Knowledge-sharing Platform for Laboratory Personnel on M
Updated : 11 months, 2 weeks ago IST
New Delhi [India], April 1: To enable knowledge sharing for laboratory personnel on technological advancement and best practices made towards assessment of Minimal Residual Disease (MRD) in Acute Leukemia & Myeloma, BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson, and Co
Read More
Folk singer Sharda Sinha passes away after long battle with cancer
Updated : 1 year, 4 months ago IST
Popular Folk singer Sharda Sinha, celebrated for her soulful Chhath songs, died on Tuesday, after battling multiple myeloma, a type of blood cancer for several years.
Read More
Music icon Sharda Sinha on ventilator; villagers, relatives prays for her
Updated : 1 year, 4 months ago IST
The 72-year-old Sinha, celebrated for her soulful renditions of folk music, particularly during the Chhath festival, is battling multiple myeloma, a type of blood cancer, which she has been fighting since 2018.
Read More
From dreams to laughter: Matt Damon pays tribute to late father's legacy
Updated : 1 year, 11 months ago IST
Actor Matt Damon recently reminisced about poignant memories of his late father, Kent Damon, who succumbed to the rare blood disease multiple myeloma in December 2017, at the age of 74.
Read More
Do you know obesity is linked to detection of blood cancer precursor? Stud
Updated : 5 months, 1 week ago IST
A new study found that obese people are more likely to develop monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that usually arises before multiple myeloma.
Read More
Obesity connected to detection of blood cancer precursor: Study
Updated : 5 months, 1 week ago IST
According to a recent study, there is a higher likelihood of monoclonal gammopathy of unknown significance (MGUS), a benign blood disorder that frequently occurs before multiple myeloma, among obese individuals.
Read More
Patients with blood cancer benefit from CAR T-cell therapy: Study
Updated : 2 years, 4 months ago IST
Patients with multiple myeloma who received idecabtagene vicleucel, popularly known as "ide-cel," a chimeric antigen receptor (CAR) T-cell treatment, had no difference in overall survival outcomes regardless of race or ethnicity.
Read More